President Trump's administration directed $50 million in federal funding toward accelerating research into psychedelic treatments like psilocybin to help combat the rising number of U.S. adults suffering from treatment-resistant depression.
President Trump's administration directed $50 million in federal funding toward accelerating research into psychedelic treatments like psilocybin to help combat the rising number of U.S. adults suffering from treatment-resistant depression.
<iframe src="https://statesidedaily.com/embed/cluster/b9b21ae897d271fce91e6e70fbf9d3cc93db01bf" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="New reasons not to be depressed about depression"></iframe>
